MedPath

Attitudes Towards Deprescribing Medications in Cancer Patients and Impact of Educational Intervention by a Clinical Pharmacist

Not Applicable
Not yet recruiting
Conditions
Cancer Patients in Palliative Care with Chronic Use of Non-oncologic Medications
Registration Number
NCT06771999
Lead Sponsor
Iuliu Hatieganu University of Medicine and Pharmacy
Brief Summary

Your participation in this study consists in responding to some questions from two questionnaires in Romanian about how you feel about deprescribing, your treatment and how you understand medical information. After that, you'll receive a brochure and watch a video with some basic information about medications and your involvement in treatment decisions and in the next visit for your cancer treatment you will be asked to answer questions from one of the initial questionnaire.

Detailed Description

Cancer patients are susceptible to using a lot of medications, with an increased risk of drug-related problems that could lead to adverse reactions from oncological drugs, hospital admissions, deteriorated performance status and increased mortality. In time, some medications may no longer be efficient, may have adverse reactions or may lose their indication and need to be stopped or replaced. This process is named deprescribing and it's supervised by a health care professional. Deprescribing can't be done without the implication of the patients, that's why it's important to investigate cancer patient's attitudes towards deprescribing non-oncologic medications in Romanian patients using a validated questionnaire (rPATD). Recent studies from Romania showed a possible lack of health care literacy that could affect patients involvement in treatment decision. In this study, we will investigate health care literacy using a validated questionnaire in Romanian (HLS-EU-Q16). In this study we will also investigate if an educational intervention (targeting patients involvement in treatment decision and mandatory, minimal information about efficacy of a treatment and its adverse reactions) conducted by a clinical pharmacist using a brochure and a video will improve their engagement and knowledge about drugs. Impact of educational intervention will be investigated by applying the rPATD questionnaire before and after the intervention.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
120
Inclusion Criteria
  • cancer patients in palliative treatment
  • ECOG 1-2
Exclusion Criteria
  • cancer patients in curative treatment
  • ECOG 3-4
  • cognitive impairment

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Impact of educational intervention performed by clinical pharmacistfrom enrollment to the next cycle of oncological treatment (14, 21 or 28 days days)

Participants will be asked to complete the same questionnaire before and after an educational intervention in order to assess if this kind of educational intervention is suitable for Romanian participants. Based on answers given to the same questions before and after the intervention, we can see if and what is changed in the perception of participants.

Secondary Outcome Measures
NameTimeMethod
Attitudes towards deprescribing medications in cancer patients in palliative treatmentfrom enrollment to the next cycle of oncological treatment (14, 21 or 28 days days) when they answer the second time

Using the rPATD questionnaire (revised Patients Attitudes Towards Deprescribing ), we assess if Romanian cancer patients are willing to have their medication deprescribed

The level of health literacyat enrollment

Using the questionnaire HLS-EU-Q16 we can asses the level of health literacy of participants

Trial Locations

Locations (1)

Constantin Opris Emergency County Hospital

🇷🇴

Baia Mare, Maramures, Romania

© Copyright 2025. All Rights Reserved by MedPath